Denta Mint
Denta Mint, licence 80071303: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Mantra Pharma Inc.
- NPN or DIN-HM
- 80071303
- Status
- Active licence
- Licence date
- 21 July 2016
- Revision date
- 30 January 2023
- Form
- Pastille
- Route of administration
- Buccale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Xylo- pentane-1,2,3,4,5-pentol Source : Xylitol | 0.56 Grammes | Not calculated |
Non-medicinal ingredients
Lactate de calcium, Gomme arabique, Saveur de menthe poivrée, Stéarate de magnésium, Cire de Carnauba
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 6.0 Année(s) | minimum: 2.0 Pastille ; maximum: 4.0 Pastille | minimum: 3.0 Tous les jours ; maximum: 4.0 Tous les jours |
| Adultes | Not specified | minimum: 2.0 Pastille ; maximum: 4.0 Pastille | minimum: 3.0 Tous les jours ; maximum: 4.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps reduce the incidence of cavities. Stimulates saliva production to relieve dryness of the mouth.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
A gradual introduction to xylitol is recommended since xylitol could have a mild laxative effect. Discontinue use if gastro-intestinal discomfort occurs.
Source
Official Health Canada record, licence 80071303
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.